Cleerly LABS vs qXR-CTR
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a comprehensive and quantitative assessment of coronary artery disease (CAD) using CCTA. This tool is ideal for detailed plaque characterization, stenosis quantification, and tracking disease progression over time to guide personalized heart disease management strategies.
View Cleerly LABS →Choose qXR-CTR if…
Choose qXR-CTR if you need an efficient and automated solution for initial screening of heart size and potential heart failure risk using standard chest X-ray images. This tool is best suited for rapidly identifying patients with an elevated cardiothoracic ratio, enabling quick triage and further diagnostic workup for suspected cardiomegaly.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | qXR-CTR |
|---|---|---|
| Pricing | Varies | Unknown |
| Deployment | Cloud, On-premise | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS offers a web-based application with advanced 3D visualization and comprehensive integration with PACS, RIS, and EHR systems via its Cleerly Proxy. Its specific integration with PowerScribe for structured reporting significantly streamlines workflow and reduces manual data entry for complex CCTA analysis. While qXR-CTR automates a specific measurement, Cleerly's interactive platform and robust reporting integration for a more intricate diagnostic task suggest a more advanced and integrated user experience.
Clinical Value
Cleerly LABSCleerly LABS provides a comprehensive, AI-powered analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis, including plaque assessment and ischemia detection, which is crucial for personalized heart disease management. This offers deeper, more actionable clinical insights into complex cardiac conditions compared to qXR-CTR's automated cardiothoracic ratio measurement for heart failure risk screening. Cleerly's approach is backed by extensive clinical validation against invasive methods and prognostic utility studies.
Pricing & Value
Cleerly LABSCleerly LABS offers transparent pricing, with a retail price of $1500 per analysis, currently discounted to $750, despite the separate cost of the CCTA scan. In contrast, qXR-CTR's pricing is not publicly disclosed, requiring direct contact for details. The transparency provided by Cleerly LABS allows for a clearer assessment of its value proposition.
Enterprise Readiness
qXR-CTRqXR-CTR demonstrates superior enterprise readiness with its flexible deployment options (cloud, on-premise, hybrid) and a broader range of security certifications, including ISO 13485:2016, ISO 27001, and GDPR compliance, in addition to HIPAA and BAA. Qure.ai's extensive global deployment in over 90 countries and 3,100+ active sites, along with numerous integration partnerships, further highlights its robust enterprise capabilities.
Innovation
Cleerly LABSCleerly LABS exhibits greater innovation by focusing on the complex and cutting-edge area of comprehensive coronary plaque characterization, quantification, and ischemia detection from CCTA, aiming to establish a new standard of care for heart attack prevention. While qXR-CTR's automation of CTR is valuable for efficiency and screening, Cleerly's multi-faceted, personalized cardiac risk assessment represents a more advanced application of AI in cardiology.
Support & Docs
Cleerly LABSCleerly LABS provides clear information regarding its client support, including stated operating hours (Monday-Friday, 10 am ET to 6 pm ET) and dedicated forms for technical support. While Qure.ai offers general company documentation and mentions local support for large projects, Cleerly's explicit details on direct client support channels offer greater transparency and accessibility for users seeking assistance.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | qXR-CTR |
|---|---|---|
| Tool Name | Cleerly LABS | qXR-CTR |
| Company | Cleerly | Qure.ai Technologies |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Primary Imaging Modality | Coronary CT Angiography (CCTA) | Chest X-ray images |
| Key Features | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, Personalized heart disease risk assessment, Tracking disease progression over time, Integration with PACS, RIS, EHR via Cleerly Proxy | Automates the measurement of the cardiothoracic ratio (CTR) |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and qXR-CTR.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or qXR-CTR
Backers
Who funded each tool's parent company.